Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ATCC J.RT3-T3.5; Leukemia; Human (Homo sapiens)

Supplier:  ATCC TIB153

Encompass

J.RT3-T3.5 is a derivative mutant of the Jurkat leukemia cell line that lacks the beta chain of the T-cell antigen receptor. The Jurkat cell line was established from the peripheral blood of a 14-year-old, male, acute T-cell leukemia patient. This cell line can be used in immune system disorder research and immunology research.

Catalog No. 50-238-3790


May include imposed supplier surcharges.

Due to product restrictions, please to purchase or view availability for this product.


Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.